2.Radiological Findings and Outcomes of Bronchial Artery Embolization in Cryptogenic Hemoptysis.
Selim KERVANCIOGLU ; Nazan BAYRAM ; Feyza GELEBEK YILMAZ ; Maruf SANLI ; Akif SIRIKCI
Journal of Korean Medical Science 2015;30(5):591-597
Management of cryptogenic massive hemoptysis is difficult, and conservative treatment may be inadequate to stop the hemorrhage. Surgery is not a reasonable option because there is no underlying identifiable pathology. This study aimed to investigate the radiologic findings and bronchial artery embolization outcomes in cryptogenic hemoptysis, and to compare the results with non-cryptogenic hemoptysis. We evaluated 26 patients with cryptogenic hemoptysis and 152 patients with non-cryptogenic hemoptysis. A comparison of the bronchial artery abnormalities between the cryptogenic and non-cryptogenic hemoptysis groups showed that only extravasation was more statistically significant in the cryptogenic hemoptysis group than in the non-cryptogenic hemoptysis group, while the other bronchial artery abnormalities, such as bronchial artery dilatation, hypervascularity, and bronchial-to-pulmonary shunting, showed no significant difference between groups. Involvement of the non-bronchial systemic artery was significantly greater in the non-cryptogenic hemoptysis group than in the cryptogenic hemoptysis group. While 69.2% of patients with cryptogenic hemoptysis also had hypervascularity in the contralateral bronchial arteries and/or ipsilateral bronchial artery branches other than the bleeding lobar branches, this finding was not detected in non-cryptogenic hemoptysis. Embolization was performed on all patients using polyvinyl alcohol particles of 355-500 microm. Hemoptysis ceased in all patients immediately after embolization. While recurrence of hemoptysis showed no statistically significant difference between the cryptogenic and non-cryptogenic hemoptysis groups, it was mild in cryptogenic hemoptysis in contrast to mostly severe in non-cryptogenic hemoptysis. Transarterial embolization is a safe and effective technique to manage cryptogenic hemoptysis.
Adult
;
Bronchial Arteries/physiopathology/*radiography
;
Bronchography
;
Case-Control Studies
;
*Embolization, Therapeutic
;
Female
;
Hemoptysis/radiography/*therapy
;
Hemorrhage/etiology
;
Humans
;
Male
;
Middle Aged
;
Recurrence
;
Tomography, X-Ray Computed
3.Endobronchial Stent Insertion to Manage Hemoptysis caused by Lung Cancer.
In Hee CHUNG ; Mi hyun PARK ; Doh Hyung KIM ; Gyeong Sik JEON
Journal of Korean Medical Science 2010;25(8):1253-1255
Hemoptysis in patients with lung cancer is not uncommon and sometimes have dangerous consequences. Hemoptysis has been managed with various treatment options other than surgery and medicine, such as endobronchial tamponade, transcatheter arterial embolization and radiation therapy. However, these methods can sometimes be used only temporarily or are not suitable for a patient's condition. We present a case in which uncontrollable hemoptysis caused by central lung cancer was successfully treated by inserting a covered self-expanding bronchial stent. The patient could be extubated and was able to undergo further palliative therapy. No recurrent episodes of hemoptysis occurred for the following three months. As our case, airway stenting is a considerable option for the tamponade of a bleeding lesion that cannot be successfully managed with other treatment methods and could be used to preserve airway patency in a select group of patients.
*Bronchi
;
Carcinoma, Non-Small-Cell Lung/*complications/therapy
;
Hemoptysis/etiology/radiography/*therapy
;
Humans
;
Intubation
;
Lung Neoplasms/*complications/therapy
;
Male
;
Middle Aged
;
Palliative Care
;
*Stents
;
Tomography, X-Ray Computed
4.Successful Removal of Endobronchial Blood Clots Using Bronchoscopic Cryotherapy at Bedside in the Intensive Care Unit.
Hongyeul LEE ; Cho Sun LEEM ; Jae Ho LEE ; Choon Taek LEE ; Young Jae CHO
Tuberculosis and Respiratory Diseases 2014;77(4):193-196
Acute airway obstruction after hemoptysis occurs due to the presence of blood clots. These conditions may result in life-threatening ventilation impairment. We report a case of obstruction of the large airway by endobronchial blood clots which were removed using bronchoscopic cryotherapy at the bedside of intensive care unit. A 66-year-old female with endometrial cancer who had undergone chemotherapy, was admitted to the intensive care unit due to neutropenic fever. During mechanical ventilation, the minute ventilation dropped to inadequately low levels and chest radiography showed complete opacification of the left hemithorax. Flexible bronchoscopy revealed large blood clots obstructing the proximal left main bronchus. After unsuccessful attempts to remove the clots with bronchial lavage and forceps extraction, blood clots were removed using bronchoscopic cryotherapy. This report shows that cryotherapy via flexible bronchoscopy at the bedside in the intensive of intensive care unit is a simple and effective alternative for the removal of endobronchial blood clots.
Aged
;
Airway Obstruction
;
Bronchi
;
Bronchoalveolar Lavage
;
Bronchoscopy
;
Cryotherapy*
;
Drug Therapy
;
Endometrial Neoplasms
;
Female
;
Fever
;
Hemoptysis
;
Hemorrhage
;
Humans
;
Intensive Care Units*
;
Radiography
;
Respiration, Artificial
;
Surgical Instruments
;
Thorax
;
Ventilation
5.Renal and Splenic Micro-Infarctions Following Bronchial Artery Embolization with Tris-Acryl Microspheres.
Ka Fai Johnny MA ; Wing Hang WONG ; Choi Yu Dilys LUI ; Lik Fai CHENG
Korean Journal of Radiology 2009;10(1):97-99
A bronchial artery embolization (BAE) is an important therapeutic method used to control acute and chronic hemoptysis. We report a case of multiple micro-infarcts involving both the kidneys and spleen, following a BAE with 500-700 micrometer crossed-linked tris-acryl microspheres (Embospheres) in a patient with bronchial artery pulmonary vein shunts. The superior penetration characteristics of the microspheres may have resulted in the greater tendency to cross the bronchial artery pulmonary vein shunts, which subsequently caused the systemic infarcts in our patient. We propose the use of larger sized microspheres (700-900 micrometer), which may aid in avoiding this complication.
Acrylic Resins/*adverse effects/therapeutic use
;
Adult
;
*Bronchial Arteries
;
Embolization, Therapeutic/*adverse effects
;
Female
;
Gelatin/*adverse effects/therapeutic use
;
Hemoptysis/therapy
;
Humans
;
Infarction/*etiology/radiography
;
Kidney/*blood supply
;
Splenic Infarction/*etiology/radiography
6.The Effectiveness of Embolotherapy for Treatment of Hemoptysis in Patients with Varying Severity of Tuberculosis by Assessment of Chest Radiography.
Woocheol KWON ; Young Ju KIM ; Young Han LEE ; Won Yeon LEE ; Myung Soon KIM
Yonsei Medical Journal 2006;47(3):377-383
The effectiveness of percutaneous embolotherapy in cases of hemoptysis due to pulmonary tuberculosis from increasing severity of lung parenchymal injury was compared. The pattern of pleural involvement, as seen on chest radiography and angiography, were comparatively analyzed in 230 patients who were available for follow-ups from March 1992 to December 2003. Chest radiography findings were classified into 4 types based on levels of complicated lesions and pleural involvement. Angiography findings were divided into 4 groups based on the level of blood supply to lesions. Early hemostasis with respect to radiographic group were as follows: Type I-92% (73/79), Type II-80% (52/65), Type III-70% (42/60), and Type IV-56% (52/92); there was an average success rate of 73% (219/296), and continued hemostasis was found in 80% of Type I patients (62/77), 77% of Type II patients (41/53), 62% of Type III patients (25/40), and 45% of Type IV patients (27/60), with an average long-term hemostatic rate of 67% (155/230). Increasing severity of pleural involvement and associated complications correlated with increasing development of systemic collateral arteries other than the bronchial artery. The severely increased circulation in systemic collateral arteries makes it difficult to predict good hemostatic results following embolization. Therefore, we recommend aggressive treatment, such as surgical intervention, after embolization in such instances.
Tuberculosis, Pulmonary/*complications/radiography
;
Treatment Outcome
;
Severity of Illness Index
;
Middle Aged
;
Male
;
Humans
;
Hemoptysis/*microbiology/radiography/*therapy
;
Follow-Up Studies
;
Female
;
*Embolization, Therapeutic
;
Angiography
;
Aged, 80 and over
;
Aged
;
Adult
;
Adolescent
7.The Effectiveness of Embolotherapy for Treatment of Hemoptysis in Patients with Varying Severity of Tuberculosis by Assessment of Chest Radiography.
Woocheol KWON ; Young Ju KIM ; Young Han LEE ; Won Yeon LEE ; Myung Soon KIM
Yonsei Medical Journal 2006;47(3):377-383
The effectiveness of percutaneous embolotherapy in cases of hemoptysis due to pulmonary tuberculosis from increasing severity of lung parenchymal injury was compared. The pattern of pleural involvement, as seen on chest radiography and angiography, were comparatively analyzed in 230 patients who were available for follow-ups from March 1992 to December 2003. Chest radiography findings were classified into 4 types based on levels of complicated lesions and pleural involvement. Angiography findings were divided into 4 groups based on the level of blood supply to lesions. Early hemostasis with respect to radiographic group were as follows: Type I-92% (73/79), Type II-80% (52/65), Type III-70% (42/60), and Type IV-56% (52/92); there was an average success rate of 73% (219/296), and continued hemostasis was found in 80% of Type I patients (62/77), 77% of Type II patients (41/53), 62% of Type III patients (25/40), and 45% of Type IV patients (27/60), with an average long-term hemostatic rate of 67% (155/230). Increasing severity of pleural involvement and associated complications correlated with increasing development of systemic collateral arteries other than the bronchial artery. The severely increased circulation in systemic collateral arteries makes it difficult to predict good hemostatic results following embolization. Therefore, we recommend aggressive treatment, such as surgical intervention, after embolization in such instances.
Tuberculosis, Pulmonary/*complications/radiography
;
Treatment Outcome
;
Severity of Illness Index
;
Middle Aged
;
Male
;
Humans
;
Hemoptysis/*microbiology/radiography/*therapy
;
Follow-Up Studies
;
Female
;
*Embolization, Therapeutic
;
Angiography
;
Aged, 80 and over
;
Aged
;
Adult
;
Adolescent
8.Malignant Hypertension with Pulmonary Alveolar Hemorrhage Needing Dialysis.
Younghun KIM ; Ki Tae BANG ; Jong Ho SHIN ; Ju Ri KIM ; Joo Heon KIM ; Jin Uk JEONG
The Ewha Medical Journal 2017;40(2):87-90
A 35-year-old man presented with progressive dyspnea and hemoptysis. His blood pressure was 230/140 mmHg and serum creatinine level was 20.13 mg/dL. Chest radiography and computed tomography revealed pulmonary hemorrhage. His renal function was low, thus emergent renal replacement therapy was required. Malignant hypertension and acute kidney injury were diagnosed, and antihypertensive therapy and hemodialysis started immediately. Renal biopsy was performed to examine the underlying disease. Typical pathological changes of malignant hypertension, fibrinoid necrosis of the afferent arterioles, and proliferative endoarteritis at the interlobular arteries were observed. His renal function improved gradually and pulmonary hemorrhage completely disappeared with administration of antihypertensive agents. Here, we report this rare case of malignant hypertension with pulmonary alveolar hemorrhage and speculate that the hemorrhage may be related to vascular injuries at the alveolar capillary level caused by malignant hypertension.
Acute Kidney Injury
;
Adult
;
Antihypertensive Agents
;
Arteries
;
Arterioles
;
Biopsy
;
Blood Pressure
;
Capillaries
;
Creatinine
;
Dialysis*
;
Dyspnea
;
Hemoptysis
;
Hemorrhage*
;
Humans
;
Hypertension, Malignant*
;
Necrosis
;
Pulmonary Alveoli
;
Radiography
;
Renal Dialysis
;
Renal Replacement Therapy
;
Thorax
;
Vascular System Injuries
9.Comparison of the Effectiveness of Embolic Agents for Bronchial Artery Embolization: Gelfoam versus Polyvinyl Alcohol.
Seok HAHN ; Young Ju KIM ; Woocheol KWON ; Seung Whan CHA ; Won Yeon LEE
Korean Journal of Radiology 2010;11(5):542-546
OBJECTIVE: The purpose of this study was to compare the results of different agents for bronchial artery embolization of hemoptysis. MATERIALS AND METHODS: From March 1992 to December 2006, a bronchial artery embolization was performed on 430 patients with hemoptysis. The patients were divided into three groups. Group 1 included 74 patients treated with a gelfoam particle (1x1x1 mm), while group 2 comprised of 205 patients treated with polyvinyl alcohol (PVA) at 355-500 micrometer, and group 3 included 151 patients treated with PVA at 500-710 micrometer. We categorized the results as technical and clinical successes, and also included the mid-term results. Retrospectively, the technical success was compared immediately after the procedure. The clinical success and mid-term results (percentage of patients who were free of hemoptysis) were compared at 1 and 12 months after the procedure, respectively. RESULTS: Neither the technical successes (group 1; 85%, 2; 85%, 3; 90%) nor the clinical successes (group 1; 72%, 2; 74%, 3; 71%) showed a significant difference among the 3 groups (p > 0.05). However, the mid-term results (group 1; 45%, 2; 63%, 3; 62%) and mid-term results excluding the recurrence from collateral vessels in each of the groups (group 1; 1 patient, 2; 4 patients, 3; 2 patients) showed that group 1 was lower than the other two groups (p < 0.05). No significant difference was discovered for the mid-term results between groups 2 and 3. Moreover, the same results not including incidences of recurrence from collateral vessels also showed no statistical significance between the two groups (p > 0.05). CONCLUSION: Polyvinyl alcohol appears to be the more optimal modality compared to gelfoam particle for bronchial artery embolization in order to improve the mid-term results. The material size of PVA needs to be selected to match with the vascular diameter.
Adolescent
;
Adult
;
Aged
;
Angiography
;
*Bronchial Arteries
;
Embolization, Therapeutic/*methods
;
Female
;
Gelatin Sponge, Absorbable/*therapeutic use
;
Hemoptysis/etiology/radiography/*therapy
;
Hemostatics/*therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Polyvinyl Alcohol/*therapeutic use
;
Treatment Outcome
10.Human Cytomegalovirus Pneumonia and Pulmonary Aspergillosis in a Patient with Acute Myelogenous Leukemia following Chemotherapy.
Gi Beom KIM ; Su Mi CHOI ; Dong Gun LEE ; Hae Rim KIM ; Kye Won LEE ; Kwan Woo NAM ; Seung Ki KWOK ; Dong Kyun SON ; Jae Hyuck CHANG ; Jung Hyun CHOI ; Wan Shik SHIN ; Chun Choo KIM
Korean Journal of Infectious Diseases 2002;34(4):261-266
Cytomegalovirus (CMV) pneumonia is one of the major causes of morbidity and mortality in immunocompromised patients such as transplant recipients. But CMV pneumonia is unusually reported among adults with leukemia who have not undergone transplantation. Because it is a cause of life-threatening pneumonia in adults with leukemia receiving potent immunosuppressive therapies, CMV has emerged as an important pathogen. We report a case of CMV pneumonia and invasive pulmonary aspergillosis in a patient with acute leukemia who have not undergone transplantation. A 31-year-old man with acute myelogenous leukemia developed high fever on day 9 of second consolidation chemotherapy. Six days later, chest radiography showed patchy consolidation with central cavity on right upper lung. Considering fungal pneumonia, amphoterin B was started, then fever was subsided. Chest CT showed necrotizing pneumonia with cavity formation in posterior segment of right upper lobe. Because of several episodes of hemoptysis, lobectomy was performed. Grossly, the area of focal necrosis with central cavity formation and multiple small interstitial nodules were observed. In the area of interstitial nodules, giant cells with intranuclear inclusion and perinuclear halo were found. In the area of focal necrosis, fungal hyphae with acute branching and septation were found. Ganciclovir and immunoglobulin were administered for CMV pneumonia. On day 62 of the chemotherapy, the patient discharged with improved symptoms. After several weeks, unrelated HLA-matched allogeneic stem cell transplantation was performed. On day 14 of transplantation, the patient died due to septic shock of unknown cause.
Adult
;
Aspergillosis
;
Consolidation Chemotherapy
;
Cytomegalovirus*
;
Drug Therapy*
;
Fever
;
Ganciclovir
;
Giant Cells
;
Hemoptysis
;
HMGB1 Protein
;
Humans*
;
Hyphae
;
Immunocompromised Host
;
Immunoglobulins
;
Intranuclear Inclusion Bodies
;
Invasive Pulmonary Aspergillosis
;
Leukemia
;
Leukemia, Myeloid, Acute*
;
Lung
;
Mortality
;
Necrosis
;
Pneumonia*
;
Pulmonary Aspergillosis*
;
Radiography
;
Shock, Septic
;
Stem Cell Transplantation
;
Thorax
;
Tomography, X-Ray Computed
;
Transplantation